Hemophilia Market (By Type: Hemophilia A, Hemophilia B, Hemophilia C; By Treatment: On-demand, Prophylaxis; By Therapy: Replacement Therapy, Gene Therapy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global Hemophilia market is estimated to hit nearly USD 17 billion by 2026. The hemophilia market islikely to grow with 5.3% CAGR during the forecast years.

Market Dynamics

The increasing initiatives at the global level to create awareness about hemophilia drugs from the government, as well as non-government organizations, is one of the prime factor boosting the market growth. Also, the increase in delivering a prophylactic treatment is likely to fuel the demand for hemophilia.

Market Insights

The importance of hemophilia drugs in delivering a gene therapy and replacement therapy is foreseen to be a key driver for market growth. As the Hemophilia is a genetic disorder, it is needed to be cured with sufficient and effective medical treatment dosages. The lack of awareness about the hemophilia is one of the major restraining factor limiting the growth of the market but the government and non-government agencies are increasing conducting programs to increase awareness about hemophilia. Hence, such activities are expected to promote the awareness and applications of hemophilia drugs and boost market growth.

According to the National Hemophilia Organization, the exact number of worldwide incidence of hemophilia are not well known, but it is estimated at more than 400,000 people. The organization also states that approximately 75% of people with hemophilia around the world still receive inadequate treatment or have no access to treatment.The manufacturers of treatment drugs for this disorder are facing a significant challenge while coming up with suitable treatment for hemophilia as there is no exact drug is available. The regulatory bodies are facing increasing pressure to create a therapy for hemophilia disorder and due to such factors, the research and development projects are increasing rapidly.

Market Segmentation

Market By Type

  • Hemophilia A
  • Hemophilia B
  • Hemophilia C

Market By Treatment

  • On-demand
  • Prophylaxis

Market By Therapy

  • Replacement Therapy
  • Gene Therapy

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

Considering the demand for Hemophilia, the North America region is dominating the hemophilia market in 2018. The North America region is predicted to continue its dominance over the end of the forecast period by holding the share of more 35%. The increasing inclination toward treatment of prophylaxis is expected to be the key factordriving the growth in this region.

  • According to a global survey conducted by WHF (World Federation of Hemophilia)in 2015, approximately 63.0% of the patients in the U.S. have opted for prophylaxis treatment. The adoption of such treatment options is resulting in the acceleration of the market.

Among the other regions, the Asia-Pacific region is anticipated to witness the substantial growth over the forecast period by registering the highest CAGR growth. Increasing awareness about hemophilia among the emerging countries including India, Indonesia, Malaysia, Japan, and others is expected to boost the market growth. In addition, the increasing disposable income backed by the advancements in the medicinal treatments such as the use of therapies for the treatment of hemophilia disorder is fuelling the demand for hemophilia.

Market Participants

The hemophilia market is highly dominated by leading players as it is a rare disorder and no accurate treatment is present for this disorder. Some of the key players in this industry include Baxalta, CSL Behring, Pfizer, Inc., Bayer Healthcare, BioMarin Pharmaceutical, Inc., Biogen, Chugai Pharmaceutical Co., Novo Nordisk, Shire Plc., and others.

These players are leveraging their current position in this market and also implementing some strategies to fuel revenue pocketing process by selling drugs. Some of the prominent strategies include geographical expansion to new regions and increasing investments in R&D for developing improved medicine alternatives.


Related Reports

Open MRI Systems Market (By Field Strength: Low, Medium, High; By Application: Brain, Spine, Abdominal, Breast, Cardiac, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global open MRI systems market is expected to grow at a CAGR of around 6.1% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 1,563.1 Mn by 2026. Magnetic resonance imaging (MRI) systems refer to the equipment which uses the medical imaging technique to form images of physiological processes of the body with the help of radiofrequency pu

Artificial Intelligence for Drug Discovery Market (By Drug Type: Small Molecule, Large Molecule; By Technology: Deep Learning, Machine Learning; By Application: Metabolic Disease, Cardiovascular Diseases, Oncology, Neurodegenerative Diseases, Others; By End use: Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The Global Artificial Intelligence for Drug Discovery Market size is expected to reach around US$ 8,149 Mn by 2026 and is expected to register a CAGR of above 42%. There is constant increase in number of patients suffering from chronic diseases across the globe and pharmaceutical companies are investing high on development of various drugs. Artificial Intelligence is able to assist manufacturers by providing s

Healthcare Staffing Market By Service (Travel Nurse, Locum Tenens, Per Diem Nurse, Allied Healthcare) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global healthcare staffing market value is expected to reach around US$ 45.2 Bn by 2026 and growing at a CAGR of around 5.2% over the forecast period 2019 to 2026. Healthcare staffing agencies are the recruitment firms that provide a broad spectrum of healthcare staff ranging from nurse and physician to allied clinician and pharmacists. Healthcare facilities often need assistan

Ambulatory Surgical and Emergency Centers Market By Service Type (Orthopedics, Ophthalmology, Gastroenterology, Plastic Surgery, Pain Management or Spinal Injections, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory surgical and emergency centers market is expected to grow at a CAGR of 6.2% over the forecast period 2019 to 2026 and market size is poised to reach US$ 203.1 Bn by 2026. Ambulatory surgery and emergency centers are medical care facilities that provide same-day surgery care which also includes consultation and diagnosis. It is a more convenient alternative to hospital based outpatient pro

Ambulatory Health Care Services Market By Type (Primary Care Offices, Medical Specialty, Emergency Departments, Surgical Specialty), By Application (Orthopedics, Ophthalmology, Gastroenterology, Plastic Surgery, Pain Management or Spinal Injections, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory health care services market size is expected to surpass US$ 4.4 Tn by 2026 and will grow at a noteworthy CAGR of 5.9% over the forecast period 2019 to 2026. Ambulatory service centers (ASC) also referred as outpatient care centers. These are medical care facilities that provide outpatient services such as consultation, diagnosis, treatment, and intervention services. It is a more convenie

Ambulatory EHR Market By Application (Patient Management, Practice Management, E-prescribing, Population Health Management, Referral Management, Health Analytics, Decision Support), By Delivery Mode (Client Server-based, Web-based), By End User Mode (Independent Ambulatory Centers, Hospital-owned Ambulatory Centers) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory EHR market size is expected to reach US$ 6.8 billion by 2026 and will grow at a CAGR of around 6.0% over the forecast period 2019 to 2026. The digital version of the patient’s record is known as the electronic health records. It includes a wide range of patient’s information such as medical history, ongoing medication, allergies, personal statistics, the status of immunization, demographics, and laborator

Cart Summary